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Abstract
Background: P2Y receptor activation may link the effect of purines to increased maximal in vitro activity of the Na,K-ATPase
in rat muscle. The hypothesis that a similar mechanism is present in human skeletal muscle was investigated with
membranes from rat and human skeletal muscle.
Results: Membranes purified from rat and human muscles were used in the Na,K-ATPase assay. Incubation with ADP, the
stable ADP analogue MeS-ADP and UDP increased the Na+ dependent Na,K-ATPase activity in rat muscle membranes,
whereas similar treatments of human muscle membranes lowered the Na,K-ATPase activity. UTP incubation resulted in
unchanged Na,K-ATPase activity in humans, but pre-incubation with the antagonist suramin resulted in inhibition with UTP,
suggesting that P2Y receptors are involved. The Na,K-ATPase in membranes from both rat and human could be stimulated
by protein kinase A and C activation. Thus, protein kinase A and C activation can increase Na,K-ATPase activity in human
muscle but not via P2Y receptor stimulation.
Conclusion: The inhibitory effects of most purines (with the exception of UTP) in human muscle membranes are probably
due to mass law inhibition of ATP hydrolysis. This inhibition could be blurred in rat due to receptor mediated activation of
the Na,K-ATPase. The different effects could be related to a high density of ADP sensitive P2Y1 and P2Y13 receptors in rat,
whereas the UTP sensitive P2Y11 could be more abundant in human. Alternatively, rat could possesses a mechanism for
protein-protein interaction between P2Y receptors and the Na,K-ATPase, and this mechanism could be absent in human
skeletal muscle (perhaps with the exception of the UTP sensitive P2Y11 receptor).
Perspective: Rat muscle is not a reliable model for purinergic effects on Na,K-ATPase in human skeletal muscle.
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Introduction
Purines (ATP and ADP) are released from muscle tissue to the
extracellular space during contractions [1] and are therefore
potential signalling molecules. Extracellular purines can activate
membrane bound G protein-coupled receptors (P2Y receptors) in
non-muscle tissue, which causes increased Na,K-ATPase activity
[2]. In rat soleus muscle, extracellular purines (0.1 to 1 mM)
augments Na,K-ATPase activity, which may be related to
stimulation of P2Y1 receptors [3]. In support of this the Na,K-
ATPase activity in membranes isolated from rat muscle is
increased by purinergic stimulation and inhibited by P2Y receptor
antagonists [4]. Based on the action of agonists and antagonists it
was suggested that the purinergic response in rat muscle
membranes involves P2Y1, P2Y3/4 and P2Y13 receptors [4]. The
purines increase both the Na+ affinity (reduced Km) and the
maximal in vitro capacity (Vmax) of the Na,K-ATPase by two
independent mechanisms: a P2Y receptor-mediated increase in
maximal activity, and a receptor independent, but phosphoryla-
tion dependent, increase in Na+ affinity [4].
P2Y receptor depend stimulation of Na,K ATPase has been
reported for rat muscle [4], it therefore appears likely that a similar
mechanism exist in human muscle. However, human skeletal
muscle express P2Y4 and P2Y11 in the plasma membrane [5]
whereas P2Y1,2,4,6,13 is expressed at the mRNA level in rat muscle
[6,7,8,9,10]. Thus, signalling via P2Y receptor activation may
differ between rat and human skeletal muscle.
The pathways from P2Y receptor activation to changes in
Na,K-ATPase activity are not known. However, activation of
phospholipase C (PLC) appears to be an intermediate step [3], but
the downstream pathway from PLC is unclear.
Muscle incubation with purines results in phosphorylation of
both the a and phospholemman (PLM) subunits of the Na,K-
ATPase in rat [4], which suggests that kinase activation is
involved. PLM phosphorylation is primarily caused by PKA and
PKC [11]. Additionally, PLM phosphorylation occurs in human
muscle as a consequence of contraction and may be related to
PKC activation as observed in mouse muscle [12]. However, it is
not known if PKC activation causes increased Na,K pump activity
in human muscle.
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The aim of the present study is to investigate the hypotheses that
1) incubation with activators of purinergic receptors cause
increased Na,K-ATPase activity in human skeletal muscle tissue
2) PKA/PKC activation causes increased Na,K-ATPase activity in
human skeletal muscle and is therefore a potential mechanism by
which P2Y receptor activation increases Na,K-ATPase activity in
human muscle.
Materials and Methods
Ethical Approval
Six healthy male volunteers (Age 24.961.3 year) participated in
the study. The human study was approved by the regional ethics
committee for the capital region of Denmark (H-A-2009-016).
These samples have been used in another study [13]. All subjects
gave written informed consent to participate. All animal handling
was conducted in accordance with Danish Animal Welfare
Regulations. The animal study was approved (P13-073) by
Department of Experimental Medicine - International Animal
Care and Use System. The animal experiments used male Wistar
rats with a body weight of 120–150 g. Rats were provided with
unlimited food and water, and were kept under a 12/12-h dark/
light cycle.
Muscle Material
Humans: After resting for 30 min, a muscle biopsy was obtained
from m. vastus lateralis under local anaesthesia (Xylocain 20 mg/
ml; AstraZeneca) using a modified Bergstro¨m needle with suction.
The muscle tissue was rapidly frozen (,30 s) in liquid nitrogen
and stored at 280uC until further analysis.
Rats: Only white vastus lateralis muscles (fast twitch fibres) were
used for the present experiments, but it has previously been
demonstrated that purinergic activation of the Na,K-ATPase
exists in slow twitch muscles [4].
Muscle Preparations and Membrane Fractionation
All sample preparations were conducted at 4uC, unless
otherwise stated. The sample protein content was determined
using a bovine serum albumin (BSA) standard (DC protein assay,
Bio-Rad, CA, USA). After mincing, muscle were homogenized for
30 s (Polytron PT 2100) in 250 mM mannitol, 30 mM L-histidine,
5 mM EGTA, and 0.1% deoxycholate, pH 6.8. The sample
(crude homogenate) was centrifuged at 30006g for 30 min, and
the resulting supernatant was centrifuged at 190,0006g spinning
for 90 min (at 4uC). The final pellet was re-suspended in assay
buffer (see below), and used for activity measurements. The
membrane purification above is necessary to remove background
activity due to other ATPases.
Measurement of Na+-stimulated Na+,K+-ATPase Activity
Na+-stimulated Na,K-ATPase activity was determined by
measuring ATP hydrolysis. Released Pi was detected using a
malachite based Biomol Green reagent (Biomol # AK-111, Enzo
Life Sciences) as previously described [4,12]. Samples were
suspended in assay buffer (10 mM KCl, 5 mM MgCl2, 50 mM
Tris-base, 5 mM EGTA, pH 7.4). Each sample contained 2–
10 mg of protein. The Na+ concentration was either 0, 5 or
40 mM (the ionic strength was kept constant by substituting NaCl
with choline chloride). 40 mM Na+ has previously been shown to
fully activate the Na+ dependent Na,K-ATPase activity [4,13].
Graphs demonstrating the Na+-dependency of the ATPase activity
have been published previously [13]. After 5 min preincubation at
37uC, the reaction was started by adding Mg-ATP to a final
concentration of 0.5 mM, and after 30 min, the reaction was
terminated by adding 1 mL Biomol Green reagent. After 30 min,
absorbance was read at 620 nm and [Pi] was calculated from a
standard curve. All samples were run in triplicate and the ATPase
activity at 0 mM Na+ was subtracted from the value at 5 or
40 mM Na+, consequently only Na+ dependent activity was
quantified. Previous studies in rat membranes demonstrated that
Na+-stimulated activity was completely inhibited by preincubation
with 2 mM of the specific Na,K-ATPase inhibitor ouabain [14].
Statistics
The mean Na,K-ATPase activity for each series of experiments
were compared using unpaired t-test (SigmaPlot software). The
experiments were carried out in pairs; one control experiment was
always carried out with an experiment using a test solution (purine
or purine+inhibitor). Thus all ATPase experiments had their own
control experiment. P,0.05 was considered to be statistically
significant.
Results
The data below represents Na,K-ATPase activity at 40 mM
Na+. In rat muscle ADP (1 mM), MeS-ADP (0.2 mM), and UTP
(1 mM) increase (P,0.05) Na,K-ATPase activity with ,67, 46,
and 32%, respectively, compared to the activity with 0.5 mM ATP
(control). Incubation with UDP (1 mM) and ATPcS (1 mM) had
no effect (Fig. 1a). The stimulatory effect of ADP in rat was
completely inhibited by pre-incubation with the P2Y receptor
antagonist suramin (100 mM) (data not shown). Likewise, the
stimulatory effect of UTP was inhibited with suramin.
Similar experiments performed with membranes from human
skeletal muscle resulted in different results: preincubation with
ADP, MeS-ADP and UDP decreased the Na,K-ATPase activity
compared to the activity with 0.5 mM ATP (Fig. 1b). Since P2Y11
receptors have been reported to be exclusively present in humans,
additional experiments were performed with the P2Y11 receptor
agonist ATPcS. Incubation with ATPcS (1 mM) decreased the
Na,K-ATPase activity in membranes from human muscle
compared to control.
The Na,K-ATPase activity was not inhibited with UTP (1 mM),
however a reduced Na,K-ATPase activity was obtained if the
inhibitor suramin (100 mM) was applied together with UTP
(Fig. 1B).
The following experiments were performed to compare the
effects of PKA and PKC activation on the Na,K-ATPase activity
in membranes from rat and human skeletal muscle. The
experiments were performed at a low Na+ concentration (5 mM)
to allow detection of the combined effect of changes in Na affinity
(Km) and Vmax. Therefore, the setup does not discriminate between
changes in Km and Vmax. The PKA activator cAMP (1 mM)
significantly increased the Na,K-ATPase activity at 5 mM Na+
both in rat (+64%) and human (+46%) samples (Fig. 2a).
Similarly, the protein kinase C activator PMA (phorbol 12-
myristate 13-acetate) (100 nM) significantly increased Na,K-
ATPase activity at 5 mM Na+ both in membranes from rat (+
48%) and human (+22%) skeletal muscle (Fig. 2b).
Discussion
The major finding in the present study was that incubations
with purinergic receptor activators caused inhibition of Na,K-
ATPase activity in membranes purified from human skeletal
muscle. In contrast, Na,K-ATPase activity was increased by
purinergic stimulation in glycolytic rat muscle. Additionally, PKA
activation by cAMP incubation and PKC activation by PMA both
Purines and Na,K-ATPase
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increased Na, K-ATPase activity in human and rat skeletal
muscle.
Effect of Purines on Na,K-ATPase Activity
The Na,K-ATPase assay used in the present study is based on
membrane purification to reduce the background activity of other
ATPases. The different purine sensitivity could therefore be the
result of different purifications of Na,K-ATPase proteins from rat
and human skeletal muscle. However, the total numbers of Na,K-
ATPase proteins (quantified with 3H-ouabain binding) in rat and
human skeletal muscle are of the same magnitude [15]. The
ATPase activity in membranes purified from rat and human
muscle is also similar (Figure 1 and 2), which indicates that the
efficiency of membrane purification in rat and human skeletal
muscle is similar. In addition, we have previously demonstrated
similar recovery (,5–6% of the isoform content in the muscle
homogenate) of the a1 and a2 isoform [4]. It is therefore unlikely
that the species variation obtained in the present study is due to
differences in membrane purification.
Figure 1. Comparison of the effects of purines on Na+ dependent Na,K-ATPase activity in membranes from rat and human skeletal
muscle. The assay was performed at 0.5 mM ATP (control, dark column). a. Rat muscle. The bars represent the Na+ stimulated Na,K-ATPase activity (+
SEM) at 40 mM Na+ (calculated from the difference between the activity at 0 and 40 mM Na+) after pre-incubation with purines (ADP, MeS-ADP, UTP,
and UDP) in the presence of 0.5 mM ATP. Mean+SE shown. *indicates different from the activity with 0.5 mM ATP. #indicates different from UTP,
n = 8. b. Human muscle. The effect of ADP, MeS-ATP, UTP, ATPcS, and UDP) in the presence of 0.5 mM ATP and 40 mM Na+ (control). In one series of
experiments the P2Y antagonist suramin (100 mM) was added together with UTP, n = 6.
doi:10.1371/journal.pone.0091175.g001
Figure 2. Effect of PKA and PKC stimulation on Na,K-ATPase activity in membranes from rat and human skeletal muscle. a. Effect of
the PKC activator PMA (phorbol 12-myristate 13-acetate) in membranes from rat and human skeletal muscle tested at 5 mM Na+, n = 6, SEM shown.
b. Effect of the PKA activator cAMP (1 mM) in membranes from rat and human skeletal muscle tested at 5 mM Na+, n = 6 *: significantly different from
control.
doi:10.1371/journal.pone.0091175.g002
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In contrast to the study hypothesis, ADP, MeS-ADP, and
ATPcS incubation resulted in Na,K-ATPase inhibition in
membranes purified from human skeletal muscle. However,
ADP, MeS-ADP and UTP incubations induced an increase of
rat muscle Na,K-ATPase activity, which confirms previous
findings [4]. In addition, ATPcS had no effect in rat muscle.
From these findings it is clear that the purinergic effect on Na,K-
ATPase activity is species dependent. It should be noted that all
incubations contained 0.5 mM ATP which per se increases the
ATPase activity ,30% [4] and as such represent a physiological
situation.
One explanation for the different effects of purinergic incuba-
tions between species may be related to a difference in P2Y
receptor isoform expression between rat and human muscle. The
P2Y1 and P2Y13 receptors are expressed in rat muscle and are
highly sensitive to ADP [6,8,9]. It is less clear which isoforms that
are expressed in human muscle. Moderate amounts of P2Y4 in the
sarcolemma and a low density of intracellular P2Y11 have been
reported [5], but the human P2Y11 receptor appears to be less
ADP sensitive [6]. The present incubation with the P2Y11 agonist
ATPcS caused an inhibition of Na,K-ATPase activity in human
muscle, suggestion that P2Y11 receptor stimulation is not
important for regulation of Na,K-ATPase activity during contrac-
tions. Moreover, incubation with UTP did not affect Na,K-
ATPase activity, but simultaneous incubation with UTP and the
P2Y antagonist suramin reduced Na,K-ATPase activity, suggest-
ing that P2Y receptors are involved in the response to UTP. The
lacking effect of UTP can be seen as a balance between a direct
inhibition (see below) mediated by UTP and a receptor mediated
stimulation.
Only few studies have discriminated between P2Y receptor
expression in muscular and microvascular compartments. This
may be of importance, as illustrated by the finding of high levels of
P2Y2 mRNA in muscle samples where immunohistochemistry
analyses revealed that the receptor is primarily expressed in the
microvascular compartment [16]. PCR measurements must
therefore be interpreted with caution.
Based on mass law action it can be suggested that an increased
purine concentration will inhibit the hydrolysis of ATP. However,
previous studies in rat have demonstrated that purines increase
Na,K-ATPase Vmax via P2Y receptors [4]. Thus, the effect of
purines can be described as a balance between inhibition and
stimulation.
Alternatively, the difference in the response to purinergic
stimulation in rat and human skeletal muscle could be due to
differences in the apparent protein-protein interaction between
membrane bound P2Y receptors, membrane bound intermediates
and the Na,K-ATPase, which has been suggested for rat muscle
[4].
Effect of PKA and PKC Activation on Na,K ATPase Activity
This study also demonstrated that both PKA and PKC
activation can stimulate the Na,K-ATPase in rat and human
skeletal muscle. The different responses to purines could therefore
not be related to differences in sensitivity and abundance of these
kinases.
However, it must be noted that there is no proof of a direct
coupling between P2Y receptors and PKA/PKC activation, other
kinases may be involved in the purinergic regulation of Na,K-
ATPase activity. The different response to purines in rat and
human could therefore also be related to differences in other signal
pathways.
In conclusion, the present results demonstrate that Na,K-
ATPase activity is inhibited by purinergic incubation, which is in
contrast to the purinergic stimulation of Na,K-ATPase activity in
rat skeletal muscle. These data demonstrate that conclusions based
on experiments with one model system, can not be uncritically
applied to another system.
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